|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| HIV | |||||
| 2 | Additional drug interventions recognized in this trial | ||||
| Nevirapine | |||||
| 3 | More general drug interventions related to this trial | ||||
| Anti-HIV Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Retroviral Agents | |||||
| Antiviral Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Nucleic Acid Synthesis Inhibitors | |||||
| Pharmacologic Actions | |||||
| Reverse Transcriptase Inhibitors | |||||
| Therapeutic Uses | |||||
| 4 | Sponsors listed in this trial | ||||
| Rigshospitalet, Denmark | |||||
| University of Copenhagen | |||||